Results 251 to 260 of about 878,879 (388)

Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang, Pauline Reynier, Antonios Douros, Oriana H. Y. Yu, Robert W. Platt, Kristian B. Filion   +5 more
wiley   +1 more source

Short-term spinal cord stimulation for refractory Elsberg syndrome in diabetic neuropathy: A case report. [PDF]

World J Clin Cases
Wang J, Yu XQ, Zhang XG, Song L, Lee J.
europepmc   +1 more source

Ivabradine, a hyperpolarization-activated channel blocker, attenuates mechanical, but not heat, hypersensitivity in hyperglycaemic and normoglycemic rat models of diabetic neuropathy

Dina Elsayegh, Omar Tluli, Maram Elzayyat, Abdelrahman Karen, Layan Albarghouthi, Abdulla Al-Emadi, Mubarak AlMaadid, Haya Al Mohannadi, Laiche Djouhri, Deana Mohamed Elsayegh, Omar Tluli, Maram Elzayyat, Abdelrahman Karen, Layan Albarghouthi, Abdulla F. Al-Emadi, Mubarak A Al-Maadid, Haya Al Mohannadi, Laiche Djouhri, Deana Mohamed Elsayegh, Omar Tluli, Maram Elzayyat, Abdelrahman Karen, Layan Albarghouthi, Abdulla F. Al-Emadi, Mubarak A Al-Maadid, Haya Al Mohannadi, Laiche Djouhri   +26 more
openalex   +1 more source

A cross-sectional study on the quality of life of patients with peripheral diabetic neuropathy pain in Hospital Tegku Ampaun Afzan, Kuantan, Malaysia

, 2018
Sinan Mohammed Abdullah Al-Mahmood, Tariq Abdul Razak, Nik Nur Fatnoon Nik Ahmad, Abdul Hadi Mohamed, Shahrin Tarmizi Bin Che Abdullah   +4 more
openalex   +2 more sources

Ethnic differences in the comparative effectiveness of second‐line type 2 diabetes medications in preventing cardiovascular disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim To investigate ethnic differences in the comparative effectiveness of sulfonylureas (SU), dipeptidyl peptidase‐4 inhibitors (DPP4i) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) on cardiovascular outcomes. Materials and Methods We identified adults with type 2 diabetes in UK electronic health records initiating SU, DPP4i or SGLT2i
Mia Harley, Christopher T. Rentsch, Elizabeth Williamson, Anoop S. V. Shah, Patrick Bidulka, Charlotte Warren‐Gash, Marleen Bokern, Rohini Mathur   +7 more
wiley   +1 more source

Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub-Saharan African Cohort. [PDF]

J Peripher Nerv Syst
Chokote SE, Lemdjo G, Idiaquez Rios JF, Anakeu AT, Ngarka L, Nfor LN, Mengnjo MK, Njamnshi WY, Kengni HNT, Ngongang RJ, Simeni G, Piameu L, Nkonda AB, Yepnjio F, Tatah GY, Thirugnanam UN, Njamnshi AK.   +16 more
europepmc   +1 more source

Continuous glucose monitoring and microvascular complications in diabetes: Bridging glycemic metrics with clinical outcomes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Continuous glucose monitoring (CGM) has emerged as a complementary and more dynamic method for evaluating glycemic control in people with diabetes. Relevant studies examining the association between CGM parameters, including time in range (TIR), glycemic variability (GV), and time in tight range (TITR), and diabetic nephropathy, retinopathy ...
Lilian Anagnostopoulou, Alexandros L. Liarakos, Ioannis Ntanasis‐Stathopoulos, Alexandros Briasoulis, Anastasios Tentolouris   +4 more
wiley   +1 more source

Efficacy and Safety of the Injection of the Traditional Chinese Medicine Puerarin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Meta‐Analysis of 53 Randomized Controlled Trials [PDF]

, 2018
Baocheng Xie, Qinghui Wang, Chenhui Zhou, Jiahuan Wu, Daohua Xu   +4 more
openalex   +1 more source

New cases expand the genotype, phenotype and therapeutic landscape of H syndrome

British Journal of Haematology, EarlyView.
Clément Triaille, Julie Beauchemin, Philippe M. Campeau, Hugo Chapdelaine, Julie Dery, Maria Kondyli, Grant Mitchell, Julie Powell, Sophie Turpin, Guilhem Cros, Fabien Touzot   +10 more
wiley   +1 more source

Assessment of thyroid cancer risk associated with glucagon‐like peptide 1 receptor agonist use

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Published literature has raised concerns regarding a causal association between glucagon‐like peptide 1 receptor agonist (GLP‐1RA) use and thyroid cancer risk in adults. In this analysis, we evaluated the association between thyroid cancer risk and GLP‐1RA use.
Tina Vilsbøll, Michael Stellfeld, Vanita R. Aroda, Sune Dandanell, Jens‐Peter David, Ceyda T. P. Kristiansen, Søren Rasmussen, Fiona L. Roberts, Laszlo Hegedüs   +8 more
wiley   +1 more source